Aviptadil, a vasodilator originally developed to treat erectile dysfunction, led to a 72% survival in critically-ill COVID-19 patients. Initial data from an US expanded access  (EA) use of RLF-100™ (aviptadil) in 90 ICU patients with critical COVID-19 and severe comorbidities point to a 72% survival 28 days after initial treatment. According to NeuroRx Inc and […]

While some of the leading players in the race for a COVID-19 vaccine are racing toward the finish line, a range of smaller challengers is still hoping to carve out a market niche in the coming months. One of those, New York’s Covaxx, is rolling out its first swath of supply deals—and touting its shot’s logistics […]

Patients with dry age-related macular degeneration who underwent subretinal transplantation of retinal pigment epithelial cells derived from human embryonic stem cells experienced stable or improved vision. “OpRegen eyes appear to tolerate the transplanted cells, may have restored retinal outer layer anatomy, may have slowed geographic atrophy progression, and may have stable or improved vision while […]